AUTHERA AS
928956164ActiveDeveloping novel FcRn-targeting biologics for therapeutic applications.
Overview
- 6
- Employees
- 10.6M NOK
- Revenue
- 2022
- Founded
Key Decision Makers
Jan Terje Andersen
Chairman & Co-founder
Inger Sandlie
Board member & Co-founder
Torleif T. Gjølberg
CSO & Co-founder
Hans Petter Tjeldflaat
CFO
+5 more contacts in Funnelfeedr
Description
Authera is a pre-clinical biotechnology company established in 2022 as a spin-off from Oslo University Hospital and the University of Oslo. The organization is dedicated to developing novel therapeutic biologics based on proprietary research into albumin and antibody-based molecules. Their core asse...
Tags
Keywords
Company Information
- Industry
- Unknown
- Legal Form
- Aksjeselskap
- VAT Number
- Unknown
Decision Makers
9 contacts in FunnelfeedrJan Terje Andersen
Chairman & Co-founder
Inger Sandlie
Board member & Co-founder
Torleif T. Gjølberg
CSO & Co-founder
Hans Petter Tjeldflaat
CFO
Simone Mester
CEO & Co-founder
Other Contacts
Eirik Sundlisæter
Medical Advisor
Jenny Skjermo Telstad
Associate Scientist
Gaia Calamera
Lead Senior Scientist
Milena A. Blaga
Senior Scientist
Similar Companies
20 similar companies in FunnelfeedrPFIZER GLOBAL TRADING
Leading global biopharmaceutical company developing life-changing medicines and vaccines.
OxThera Intellectual Property AB
0 employeesDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
OxThera AB
0 employeesDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
Sixera Pharma AB
1–4 employeesSmall biotech developing first treatment for rare Netherton syndrome.
QureTech Bio AB
5–9 employeesDeveloping novel synthetic antibiotics to combat drug-resistant bacteria.
Browse More
AUTHERA AS Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo